| Document |
Document Title |
|
WO/2020/253445A1 |
Provided are an organic electroluminescent material and an organic luminescent device comprising the organic electroluminescent material. The organic electroluminescent material has the structural formula of (I). Compared with a monoamin...
|
|
WO/2020/255964A1 |
Provided is an actinic ray-sensitive or radiation-sensitive resin composition by which a pattern having excellent LWR performance can be formed. Provided are: a resist film and a pattern forming method which use the actinic ray-sensitive...
|
|
WO/2020/253283A1 |
Provided in the present invention is a novel diaroyl carbazole compound, used together with a carbazolyl oxime ester photoinitiator to show a significant synergistic initiation effect in a photoresist composition; the best sensitising ef...
|
|
WO/2020/252628A1 |
Oxime ester compounds represented by formulas (I) and (II) containing an unsaturated five-membered heteroaromatic ring structure, wherein m, n, n', A1, A2, R1, R2, R3, R4, R5, R6, R6', R7, and R7' are defined in the specification. The co...
|
|
WO/2020/250223A1 |
The invention relates to a novel substituted amino acids, agricultural compositions comprising the novel substituted amino acids, and their use for controlling undesired plant growth alone or in combination with crop protection agents su...
|
|
WO/2020/252456A1 |
Various embodiments relate to compounds, having structures according to Structure A or Structure B, as specified herein. The compounds according to various embodiments may inhibit NT5C2 nucleotidase. The compounds according to various em...
|
|
WO/2020/248755A1 |
Disclosed are a nitrogen-containing compound, an organic electroluminescent device and a photoelectric conversion device, belonging to the technical field of electronic components. The structure of the nitrogen-containing compound is as ...
|
|
WO/2020/248943A1 |
The present application provides a nitrogen-containing compound, an electronic component and an electronic device, and belongs to the technical field of organic materials. The structure of the nitrogen-containing compound is as shown in ...
|
|
WO/2020/250880A1 |
The present invention addresses the problem of providing a compound having high photobase generation efficiency. The present invention is a carbamoyl oxime compound represented by general formula (I). In the formula, R1, R2, R3, R4, R5, ...
|
|
WO/2020/244323A1 |
Disclosed are a preparation method for a cis-p-mentha-1,8-secondary amine compound and a herbicidal application thereof. The method comprises: using a cis-p-mentha-1,8-di-schiff base compound as a raw material, putting reducing agents in...
|
|
WO/2020/240178A1 |
A compound, e.g. a diamine ligand, represented by the following general formula (1): (Formula (1)) wherein each * represents an asymmetric carbon atom; X represents a group selected from one of an ester (e.g. a t-butyl ester); a thioeste...
|
|
WO/2020/238862A1 |
The present invention provides a fluorene initiator, a photocurable composition comprising same, and an application thereof. The fluorene photoinitiator has a structure represented by formula (I) or formula (II). In the photoinitiator, o...
|
|
WO/2020/232742A1 |
Provided is a bifenthrin derivative, wherein same has a structural formula as shown in formula (I). The derivative is obtained mainly through modifying and transforming benzene rings at the ortho-position and terminal-position on an inte...
|
|
WO/2020/185054A9 |
The present invention provides a novel compound and an organic light emitting device using same.
|
|
WO/2020/225569A1 |
The present invention relates to a compound of formula (I), or a pharmaceutically acceptable salt or hydrate thereof, wherein: the group X-Y is -NHSO2- or -SO2NH-; Z is a monocyclic aryl or heteroaryl group, each of which is optionally s...
|
|
WO/2020/220942A1 |
A compound, an organic electroluminescent device containing the compound, and an application thereof. The compound has a structure shown in (I).
|
|
WO/2020/221217A1 |
A fluorescent dye, a preparation method therefor, and a use thereof; the fluorescent dye is sensitive and specific to viscosity response, has the advantage of low background fluorescence, and can be used as a fluorescence activated dot l...
|
|
WO/2020/221038A1 |
A compound represented by formula (I) or a pharmaceutically acceptable salt, a stereoisomer, a tautomer, a polymorph, a solvate, an N-oxide, an isotope labeled compound, a metabolite or a prodrug thereof, a pharmaceutical composition and...
|
|
WO/2020/216701A1 |
The present invention provides acyl sulfonamide compounds of general formula (I): in which X, R1, R2, R3, R4, R5, R6, Ra and Rb are as described and defined herein, methods of preparing said compounds, intermediate compounds useful for p...
|
|
WO/2020/220020A1 |
The present invention includes novel compounds and compositions including heteroaromatic Silicon-Fluoride-Acceptors, which are useful for PET imaging, as well as methods for making and using these compounds. The present invention further...
|
|
WO/2020/216298A1 |
Disclosed are a compound as shown in formula I, a stereoisomer thereof, and a pharmaceutically acceptable salt thereof. The present invention also relates to a pharmaceutical composition containing the compound of formula I and use of th...
|
|
WO/2020/218187A1 |
An organic electroluminescent element which comprises a light emitting layer between a positive electrode and a negative electrode facing each other, and which is characterized in that: the light emitting layer contains a first host, a s...
|
|
WO/2020/209292A1 |
An organic electroluminescent element which comprises a cathode, an anode, and a luminescent layer disposed between the cathode and the anode, wherein the luminescent layer comprises a compound represented by formula (1) and one or more ...
|
|
WO/2020/209293A1 |
An organic electroluminescent element includes a cathode, an anode, and an organic layer disposed between the cathode and the anode, wherein the organic layer includes a light-emitting layer and a first layer, the first layer is disposed...
|
|
WO/2020/209299A1 |
An organic electroluminescent element comprising a cathode, an anode, and an organic layer disposed between the cathode and the anode, wherein the organic layer comprises a light-emitting layer and a first layer, the first layer is dispo...
|
|
WO/2020/210582A1 |
The present invention relates to the discovery of small molecule compounds that act act as GLP-1R agonists and/or as positive allosteric modulators (PAMs) of GLP-1R. Such compounds are useful to treat, ameliorate, and/or prevent insulin ...
|
|
WO/2020/199945A1 |
The present invention relates to the technical field of medicine, and discloses a compound as shown in formula (I) and a preparation method therefor, a pharmaceutical composition and the use thereof. In particular, further disclosed in t...
|
|
WO/2020/202177A1 |
The present invention provides a solvent-free charge transfer liquid formed by dialkoxynaphthalene as a donor and a new derivative molecule of naphthalenediimide of formula (2) as an acceptor.
|
|
WO/2020/159889A9 |
Provided herein are compounds comprising a three-ring core, such as compounds of Formula (I), Formula (I-i), Formula (I-A), Formula (I-A-i), Formula (I-A-i-1), Formula (I-B), Formula (I-B-i), Formula (I-B-i-1), Formula (II), Formula (II-...
|
|
WO/2020/196667A1 |
This polymer includes a structural unit (1) based on a monomer represented by formula (1), wherein the contained amount of a structural unit based on a monomer having a polycyclic structure is 35 mol% or less. In formula (1): R1 represen...
|
|
WO/2020/182070A1 |
Disclosed by the present invention are a compound using triarylamine that contains pyrene or azapyrene as a core and an application thereof. The structure of the organic compound provided by the present invention is as shown in general f...
|
|
WO/2020/180019A1 |
The present invention provides a novel compound and an organic light emitting device using same.
|
|
WO/2020/181165A1 |
Provided herein are compounds of formula (I), compositions comprising the compounds and method of treating various diseases with the compounds and compositions.
|
|
WO/2020/178053A1 |
Phenol derivatives of general formula (I) and (II), wherein meanings of the substituents are indicated in the description, their pharmaceutically acceptable salts, together with the processes for their preparation, their use as antimicro...
|
|
WO/2020/180022A1 |
The present invention provides a novel compound and an organic light emitting device using same.
|
|
WO/2020/180624A1 |
Compounds are provided having the structure of Formula (I): or a pharmaceutically acceptable isomer, racemate, hydrate, solvate, isotope, or salt thereof, wherein A, X1, X2, Q, R1, R2 and n are as defined herein. Such compounds function ...
|
|
WO/2020/169768A1 |
The invention discloses a method for the preparation of fluoro alkylated compounds by homogeneous Ni catalyzed fluoro alkylation with fluoro alkyl halides in the presence of a base.
|
|
WO/2020/166874A1 |
The present invention provides a novel compound and an organic light-emitting diode using same.
|
|
WO/2020/166873A1 |
The present invention provides a novel compound and an organic light emitting device comprising same.
|
|
WO/2020/162824A1 |
The present disclosure relates to compounds of formula IVa or IVb, or salts thereof, as intermediates in the manufacture of conducting redox polymers. L is a covalent linker moiety and R is a reversible redox group. The disclosure furthe...
|
|
WO/2020/162156A1 |
The present invention provides a compound which enables a light emitting element to have excellent luminance life. A compound which is represented by formula (1). (In the formula, n represents an integer of from 2 to 20 (inclusive); ...
|
|
WO/2020/161275A1 |
The present invention relates to novel, optionally substituted, N-benzyl-2- phenoxybenzamide derivatives of formula (I), as modulators of EP4 and/or EP2 receptors of prostaglandin E2 (PGE2), to processes for their preparation, to pharmac...
|
|
WO/2020/159279A1 |
The present specification provides a compound represented by chemical formula 1 and an organic light-emitting element comprising same.
|
|
WO/2020/158841A1 |
The purpose of the present invention is to provide a novel compound capable of accelerating the proliferation of cells in cell culturing (particularly three-dimensional cell culturing). A hydrazide compound represented by formula (I) [wh...
|
|
WO/2020/160321A1 |
The present invention provides compounds and methods for treating MKP5 modulated disease. In certain embodiments, the MKP5 modulated disease is a fibrotic disease.
|
|
WO/2020/156238A1 |
Disclosed in the present invention is a copper-catalyzed method for preparing an aldehyde or ketone compound by oxidizing alcohol by using oxygen as an oxidant: at room temperature, a copper salt and a nitrogen oxide free radical are use...
|
|
WO/2020/156512A1 |
Disclosed in the present invention is an aromatic (hetero)cyclic ether compound having insecticidal activity, or an optical isomer, cis-trans isomer, or agrichemically acceptable salt thereof. Also disclosed in the present invention is a...
|
|
WO/2020/158870A1 |
The purpose in one embodiment of the present invention is to provide a therapeutic for Parkinson's disease, etc. A compound represented by formulas (1), (2), or (8) or a pharmacologically acceptable salt thereof can be used in the treatm...
|
|
WO/2020/154499A1 |
In one aspect, compounds of Formula AA, or a pharmaceutically acceptable salt thereof, are featured: (Formula AA) or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula A can be as defined anywhere herein.
|
|
WO/2020/154321A1 |
In one aspect, compounds of Formula AA, or a pharmaceutically acceptable salt thereof, are featured: Formula (AA) or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula A can be as defined anywhere herein.
|
